Patients demonstrated no impairment in SI gating, but a robust gating deficit in SII, supporting the presence of cross modal gating deficits in schizophrenia.
The results suggest that high gene count, cooperativity of at least two, tight repression, and balanced decay rates are necessary for robust gates.
This led to a context-dependent [i.e., peripheral blood/tumor/lymph node (LN)] essential marker set and robust gating strategy for the analysis of Tregs by flow cytometry.
As we do not intend for our model to be used as a robust gating model that can be plugged into a cell or tissue model, such a solution may be irrelevant in any case.
In summary, consensus was reached concerning the use of an essential marker set comprising antibodies to CD3, CD4, CD25, CD127, Foxp3, Ki67, and CD45RA and a corresponding robust gating strategy for the analysis of Tregs in human samples.
In conclusion, we propose an essential marker set comprising antibodies to CD3, CD4, CD25, CD127, Foxp3, Ki67, and CD45RA and a corresponding robust gating strategy for the context-dependent analysis of Tregs by flow cytometry.
It has recently been shown that a robust quantum gate can be implemented even in the presence of large micromotion [16].
Parameter variation simulations yield further insights into the design principles necessary for building robust genetic gates.
Overall, we believe the use of bellows-based respiratory gating provides a simple robust way to gate PET/MRI data without affecting MR imaging.
